Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy
Name:
Pediatric_Pulm_Asthma_Link_Sub ...
Size:
222.8Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Trivedi, MichellePatel, Janki
Hoque, Shushmita
Mizrahi, Raphael
Biebel, Kathleen
Phipatanakul, Wanda
Lemon, Stephenie C
Byatt, Nancy
Gerald, Lynn B
Rosal, Milagros
Pbert, Lori
Affiliation
Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot SciIssue Date
2019-12-19
Metadata
Show full item recordPublisher
WILEYCitation
Trivedi, M, Patel, J, Hoque, S, et al. Alignment of stakeholder agendas to facilitate the adoption of school‐supervised asthma therapy. Pediatric Pulmonology. 2019; 1– 11. https://doi.org/10.1002/ppul.24611Journal
PEDIATRIC PULMONOLOGYRights
© 2019 Wiley Periodicals, Inc.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background School-supervised inhaled corticosteroid (ICS) therapy improves pediatric asthma medication adherence, outcomes, and morbidity. However, school-supervised ICS therapy has not been widely adopted into practice. We developed Asthma Link (TM) as a sustainable, low-cost model of school-supervised asthma therapy, designed for real-world adoption. Initial outcomes of Asthma Link (TM) demonstrated a significant improvement in health outcomes. Objective In this study, we examined the perspectives of Asthma Link (TM) participants to identify systems-level barriers and facilitators to refine the Asthma Link (TM) protocol and facilitate real-world uptake of school-supervised asthma therapy. Methods Using qualitative research methods, we interviewed 29 participants in Asthma Link (TM) from 2016 to 2018. Semi-structured interviews were conducted over the phone. Interviews were transcribed and the transcripts were coded to identify major themes within and across stakeholder groups. Results Stakeholders agreed on many facilitators for successful Asthma Link (TM) execution including the brief and easy to follow procedures and the perceived beneficial health impacts for children involved. Some of the barriers identified were deviations from the protocol and insurance companies denying coverage for two inhalers. However, the participants did propose solutions to address these barriers. Conclusion Asthma Link (TM) is a low-cost, sustainable model of school-supervised asthma therapy that leverages the established infrastructure and collaboration of medical providers, school staff, and families. In this study, we elicited the perspectives from these stakeholder groups and identified an agreement in several facilitators, barriers, and proposed solutions that will ultimately inform refinement of the program protocol and support real-world adoption of Asthma Link (TM) and other similar models.Note
12 month embargo; published online: 19 December 2019ISSN
8755-6863PubMed ID
31856415Version
Final accepted manuscriptSponsors
National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [KL2TR001454, UL1TR001453-01, K24AI108622]ae974a485f413a2113503eed53cd6c53
10.1002/ppul.24611